Disease: Substance Abuse technologies available for licensing from the University of California

Available Technologies - Technology Categories

All Categories > Medical > Disease: Substance Abuse

Tech ID	Title
22541	New Treatment for the Prevention and Reversal of Non-Alcoholic Fatty Liver Disease (NAFLD) Researchers at the University of California, Irvine have found a new use for a known compound for treatment of fatty liver disease which has been shown to be effective in animal studies. (more...)
21739	Bromocriptine in the Treatment Of Alcoholics with the A1 Allele of Drd2 (more...)
21310	Novel, reliable, non-invasive and inexpensive assay to detect steroids Researchers at UCSF have developed a novel method that can detect and measure the total activity of any steroid from urine in under two days. The assay leads to reproducible results and measurements can be easily automated. (more...)
19842	Successful web-based smoking cessation program yields 20% abstinence rates at one year. Background: Cigarette smoking is the single most preventable cause of premature death in the United States. Each year, one in every five deaths, (about 443,000 in total) is smoking related. The health risks associated with smoking translate into annual healthcare costs of more than $96 billion, with costs associated with second hand smoking averaging $10 billion. Interestingly, 70% of the 43.4 million U.S. adult smokers report that they want to quit completely and more than 40% try to quit each year. However, smoking cessation is extremely difficult; in fact, only about 4% - 7% of people are able to remain smoke free for six months on any given attempt. These success rates dramatically increase to between 14% - 27% if smokers use medicines or behavioral therapies, but such methods may be expensive for both the insurer and patient, inconvenient, or difficult to access. Therefore, it is imperative that a successful, convenient, and cost-effective smoking cessation aid be developed. Invention: Prominent University of California clinicians, Ricardo F. Muñoz, Ph.D. and Eliseo J. Pérez-Stable, M.D. have developed an extremely successful, web-based, smoking cessation program. The program takes eight weeks to complete and combines a smoking cessation guide with individually tailored advice, optional email reminders, and an optional mood management program. Since 2002, over 17,500 smokers from over 155 countries have participated in a series of randomized controlled smoking cessation trials using this program. The study boasts an impressive success rate, with 20% of the participants remaining smoke-free after one year. Significantly, this success rate is comparable to those seen for nicotine replacement therapies, or smoking cessation groups, yet the web program has the important advantages of reducing the cost per patient and increasing the ease of patient access. Furthermore, this fully developed stand alone program is available in both English and Spanish, making it accessible to virtually every American smoker. http://www.stopsmoking.ucsf.edu or http://www.dejardefumar.ucsf.edu (more...)

Back To Search